ATHENA Study - The Role of Circulating Plasma MicroRNAs in Paediatric Patients with Untreated Primary Hypertension:

Michał Szyszka1, Ceren Eyileten2,3, Jolanta Małyszko4

  • 1Department of Pediatrics and Nephrology, Doctoral School, Medical University of Warsaw, Warsaw, Poland.

Abstract

Insights

MicroRNA-27b and microRNA-133a are underexpressed in hypertensive children, potentially serving as biomarkers for hypertension. MicroRNA-16 may indicate elevated diastolic blood pressure in pediatric hypertension.

Area of Science:

  • Pediatric Cardiology
  • Molecular Biology
  • Genetics

Background:

  • The role of microRNAs in pediatric primary hypertension is not well understood.
  • This study investigates specific microRNAs in hypertensive children.

Purpose of the Study:

  • To examine the expression of microRNAs (-16, -21, -27a, -27b, -133a, -145) in untreated hypertensive children.
  • To assess microRNA response to aerobic exercise.
  • To correlate microRNA levels with blood pressure and hypertension-mediated organ damage (HMOD).

Main Methods:

  • Observational, hypothesis-generating study with 56 hypertensive and 59 healthy children.
  • Plasma microRNA levels and clinical parameters measured pre- and post-aerobic exercise.
  • Analysis included blood pressure, vascular function, and HMOD parameters.

Main Results:

  • Hypertensive children showed lower baseline microRNA-27b and microRNA-133a expression.
  • Aerobic exercise increased microRNA-27b, -133a, and -145 in controls, and microRNA-145 in hypertensive children.
  • MicroRNA-16 was a significant predictor of elevated diastolic blood pressure; microRNA-27b showed potential as a biomarker.

Conclusions:

  • MicroRNA-27b and microRNA-133a are underexpressed in pediatric primary hypertension.
  • These microRNAs may serve as potential biomarkers for hypertension in children.
  • MicroRNA-16 may indicate diastolic hypertension in pediatric patients.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...